Eli Lilly and Company has announced plans to build a new $6.5 billion manufacturing facility at Generation Park in Houston, ...
Kashiv BioSciences commercially launched Pexegra, a biosimilar referencing Neulasta, and Filra, a biosimilar referencing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback